Cours A.P. Pharma, Inc. OTC Bulletin Board
Actions
APPA
US00202J2033
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
CA 2024 * | 148 M 133 M | CA 2025 * | 178 M 160 M | Capitalisation | 502 M 450 M |
---|---|---|---|---|---|
Résultat net 2024 * | -14 M -12,56 M | Résultat net 2025 * | 1 M 897 k | VE / CA 2024 * | 3,39 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 2,82 x |
PER 2024 * |
-37
x | PER 2025 * |
499
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 99,3% |
Dernier transcript sur A.P. Pharma, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/02/23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16/06/23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/11/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/02/23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20/09/21 |
Craig Johnson
BRD | Director/Board Member | 62 | 13/01/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+23,13% | 46,93 Md | |
+37,69% | 39,08 Md | |
-8,73% | 38,48 Md | |
+28,09% | 31,01 Md | |
-12,26% | 26,14 Md | |
+10,57% | 25,88 Md | |
+45,05% | 14,15 Md | |
+32,23% | 12,53 Md | |
-6,56% | 11,36 Md |
- Bourse
- Actions
- Action HRTX
- Action APPA